IBEX Limited
NASDAQ:IBEXInformation Technology Services
-$0.52 today
- Market cap
- $740.03M
- Beta
- 0.70
- P/E (TTM)
- 8.5
- EPS (TTM)
- $3.51
Volume 0.14M
Average 0.12M
Big Five Numbers
IBEX Limited growth analysis
Start with the long-run numbers that show whether IBEX compounds: return on capital and growth in sales, earnings, equity, and free cash flow.
Big Five Numbers
CAGR by period · ROIC shows average
| Metric | 10yr | 5yr | 3yr | 1yr |
|---|---|---|---|---|
EPS | N/A | N/A | +27.1% | +28.3% |
Revenue | N/A | N/A | +4.2% | +9.8% |
Equity | N/A | N/A | +13.7% | -2.3% |
Cash | N/A | N/A | -32.0% | -75.5% |
ROIC | N/A | 12.1% | 14.7% | 16.7% |
Analysis
Latest growth is strongest in EPS at +28.3% and weakest in Cash at -75.5%. Three-year average ROIC is 14.7%, which helps show whether that growth is being earned efficiently.
Growth analysis
Is growth accelerating or fading?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +27.1% | +22.9% (3yr)2 analysts |
| Revenue | N/A | N/A | +4.2% | +11.8% (3yr)2 analysts |
| Net Income | N/A | N/A | +19.8% | +20.7% (3yr)2 analysts |
| EBIT | N/A | N/A | +31.2% | +18.3% (3yr)2 analysts |
Analysis
Recent growth has been strongest in EBIT at +31.2% over three years. Forward estimates point to EPS at +22.9% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Revenue segments
Where does the growth come from?
Break revenue down by product and geography to see which parts of the business drive the trend.
Revenue by segment
Where IBEX earns its revenue, as reported in company filings
No segment data for this view.
Free cash flow
Does growth turn into cash?
Check whether reported growth converts into free cash flow after capital spending.
Free Cash Flow
Net Income to FCF bridge
FY2025
Analysis
FY2025 free cash flow is $27.3M. FCF conversion is 74.0% of net income. Operating cash flow was $45.7M, with capex of -$18.4M. The largest bridge item is Working Capital at -$26.3M.
Price targets
What do analysts expect from the price?
Compare the current price with the low, average, and high analyst targets.
Wall Street price targets
1-year price history with analyst consensus target
Unlock analyst target range
Sign in free to see low, average, high targets and implied upside for IBEX.
Analyst ratings
How do analysts rate the stock?
Review the buy, hold, and sell split and recent upgrades and downgrades.
Analyst ratings
Buy, hold, and sell recommendations and recent rating changes
Unlock analyst ratings
Sign in free to see the buy/hold/sell breakdown and recent rating changes for IBEX.
Competitor growth
How does IBEX Limited grow against peers?
Compare historical and forecast growth with similar companies.
Competitor Growth
Peer CAGR comparison & forward estimates
| Company | Market Cap | 10yr | 5yr | 3yr | Fwd |
|---|---|---|---|---|---|
Concentrix Corporation CNXC | $2.00B | — | +15.8% | +15.8% | +0.0% (4yr)1 analysts |
Conduent Incorporated CNDT | $194.60M | -7.5% | -6.1% | -7.6% | -9.3% (3yr)2 analysts |
TTEC Holdings, Inc. TTEC | $145.68M | +5.2% | +1.9% | -4.4% | -2.1% (3yr)1 analysts |
Questions
Growth questions
Common questions about IBEX's growth, answered from reported and forecast figures.
Is IBEX growing revenue?
Revenue grew 9.8% year over year, from $508.57M to $558.27M.
Is IBEX turning growth into profit?
The latest net margin is 6.6%, which shows how much revenue became net income.
Continue the stock analysis
Jump to another research area for this company.